Literature DB >> 16984053

Expanding the scientific basis of health technology assessment: a research agenda for the next decade.

Renaldo N Battista1.   

Abstract

OBJECTIVES: The complexity of health technology assessment (HTA) has increased, in part because of its evolution through three distinct phases: the machine, the clinical outcomes, and the delivery models. However, the theoretical foundation for the field remains underdeveloped.
METHODS: It is high time for HTA to bring together aspects of conceptual and theoretical works from other fields to strengthen the foundation of HTA.
RESULTS: Many challenges await the further development of HTA. They can be captured around three research themes: adapting HTA to an evolving analysis object; translating HTA results into policy, management, and practice decisions; and evaluating organizational models of HTA.
CONCLUSIONS: Consolidating the scientific basis of HTA is essential if we are to succeed in increasing the relevance of HTA in some of the most challenging health-related decisions that we will make as individuals and societies.

Mesh:

Year:  2006        PMID: 16984053     DOI: 10.1017/s0266462306051130

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  9 in total

1.  Micro HTA as a tool for clinical governance: the experience of the Breast Unit in "Santa Maria" Terni Hospital.

Authors:  A Sanguinetti; R Lucchini; R Triola; S Avenia; G Bistoni; C Conti; S Santoprete; N Avenia
Journal:  G Chir       Date:  2013 Nov-Dec

2.  Health technology assessment and thyroid surgery.

Authors:  R Lucchini; A Sanguinetti; M Monacelli; R Triola; S Avenia; C Conti; S Santoprete; N Avenia
Journal:  G Chir       Date:  2013 Jul-Aug

Review 3.  Virtual community consultation? Using the literature and weblogs to link community perspectives and health technology assessment.

Authors:  Jackie M Street; Annette J Braunack-Mayer; Karen Facey; Richard E Ashcroft; Janet E Hiller
Journal:  Health Expect       Date:  2008-04-22       Impact factor: 3.377

Review 4.  Analysis of the impact of professional involvement in evidence generation for the HTA Process, subproject "cochlear implants": methodology, results and recommendations.

Authors:  S Berrettini; E Arslan; A Baggiani; S Burdo; E Cassandro; D Cuda; R Filipo; P Giorgi Rossi; P Mancini; A Martini; A Quaranta; N Quaranta; G Turchetti; F Forli
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-10       Impact factor: 2.124

5.  Institutionalizing telemedicine applications: the challenge of legitimizing decision-making.

Authors:  Paolo Zanaboni; Emanuele Lettieri
Journal:  J Med Internet Res       Date:  2011-09-28       Impact factor: 5.428

6.  The prevention of postmenopausal osteoporotic fractures: results of the Health Technology Assessment of a new antiosteoporotic drug.

Authors:  Chiara de Waure; Maria Lucia Specchia; Chiara Cadeddu; Silvio Capizzi; Stefano Capri; Maria Luisa Di Pietro; Maria Assunta Veneziano; Maria Rosaria Gualano; Flavia Kheiraoui; Giuseppe La Torre; Nicola Nicolotti; Antonella Sferrazza; Walter Ricciardi
Journal:  Biomed Res Int       Date:  2014-02-04       Impact factor: 3.411

7.  Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients.

Authors:  A Poscia; J Stojanovic; F Kheiraoui; E M Proli; F Scaldaferri; M Volpe; M L Di Pietro; A Gasbarrini; L Fabrizio; S Boccia; C Favaretti
Journal:  Biomed Res Int       Date:  2017-07-06       Impact factor: 3.411

8.  A proposal of a new evaluation framework towards implementation of genetic tests.

Authors:  Erica Pitini; Elvira D'Andrea; Corrado De Vito; Annalisa Rosso; Brigid Unim; Carolina Marzuillo; Antonio Federici; Emilio Di Maria; Paolo Villari
Journal:  PLoS One       Date:  2019-08-05       Impact factor: 3.240

9.  Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles.

Authors:  Viktor Dombrádi; Erica Pitini; Carla G van El; Anant Jani; Martina Cornel; Paolo Villari; Muir Gray; Klára Bíró
Journal:  BMC Health Serv Res       Date:  2019-11-11       Impact factor: 2.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.